SK Biopharm Reports 2Q Operating Loss of 40.1 Billion KRW... Deficit Reduced

[Asia Economy Reporter Kwon Jaehee] SK Biopharm announced on the 11th that its consolidated operating loss for the second quarter of this year was tentatively estimated at 40.072 billion KRW, showing a decrease in the deficit compared to the same period last year (65.081 billion KRW).

Sales increased by 122.92% to 53.433 billion KRW. Net loss was 45.4 billion KRW, with the deficit narrowing by 32.23%.